AstraZeneca
investing in new launches near and mid term pipeline phase trials initiated across medicines phase trials initiated with blockbuster potential regulatory approvals in major markets new medicines approved and on track to deliver on ambition for at least launches by | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
February 2024
Slide
8 of 45
Related slides by other companies
BioNTech
Results
August 2020
initiated phase trial for our agonist in | BioNTech
9 Meters Biopharma
Investor Presentation
September 2022
vibrant phase trial design meters | 9 Meters Biopharma
ATAI
Investor Presentation
March 2023
phase proof of concept trial design all subjects tid tid placebo trial status in data anticipated randomized week study of and patients with | ATAI
Erasca
Investor Presentation
August 2023
proposed pivotal phase trial designs creative strategy includes high randomized melanoma trial and tissue agnostic indication | Erasca
Other recent decks by AstraZeneca
See all presentations (27 decks)
Investor Conference
January 2024
Results
November 2023
Results
July 2023
Investor Event
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io